Skip to main content

Exane Derivatives

SEC CIK
0001623883
Latest filing
Jul 12, 2022

CKPT holding history

Checkpoint Therapeutics, Inc. in every 13F filed by Exane Derivatives, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CKPT overviewAll 13F holders of CKPTFull Q2 2022 holdings

Shares (Q2 2022)
1,611
Value
$1.66K
% of portfolio
<0.1%
Quarters held
4
Since Q3 2021
Holdings of CKPT by Exane Derivatives, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20221,611$1.66K<0.1%−27,242−94.4%ReducedHolders
Q1 202228,853$51.1K<0.1%−2,409−7.7%ReducedHolders
Q4 202131,262$97.2K<0.1%−16,968−35.2%ReducedHolders
Q3 202148,230$159.2K<0.1%+48,230NewHolders